FindTrial
Sign In

The role of amphiregulin in Ovarian hyperstimulation syndrome and the underlying molecular mechanism

The role of amphiregulin in Ovarian hyperstimulation syndrome and the underlying molecular mechanism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014462
Enrollment
Unknown
Registered
2018-01-16
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian hyperstimulation syndrome

Interventions

1:IVF
2:IVF

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: OHSS patients and Non-OHSS patients

Exclusion criteria

Exclusion criteria: patients with polycystic ovarian syndrome (PCOS), endometriosis, diminished ovarian reserve, chromosome abnormality, or hydrosalpinx.

Design outcomes

Primary

MeasureTime frame
AREG;—

Countries

China

Contacts

Public ContactFang Lanlan

The First Affiliated Hospital of Zhengzhou University

fanglly@163.com+86 13673355291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026